Correct option is C
Statement A: -"Treating the cells with a PTEN inhibitor increases GeneX expression."
PTEN is a phosphatase that dephosphorylates PIP3, a second messenger that activates PI3K/AKT signaling.
Inhibiting PTEN leads to increased AKT activity, which, in turn, phosphorylates FOXO and sequesters it in the cytoplasm.
This reduces FOXO activity, which typically leads to decreased GeneX expression (since FOXO usually activates GeneX transcription).
Therefore, Statement A is incorrect. Inhibiting PTEN would likely decrease GeneX expression, not increase it.
Statement B: - "A cell line with an AKT (S308A) mutation has increased GeneX expression."
AKT is a kinase that is activated by PI3K signaling. The S308A mutation likely reduces AKT activation or blocks its function.
This reduction in AKT activity means less phosphorylation of FOXO, which results in greater FOXO activity.
FOXO is a transcription factor that increases GeneX expression, so GeneX expression would increase in this mutant.
Statement B is correct.
Statement C: - "Change in GeneX expression due to a ligand-binding defective insulin receptor is partly reversed by a PTEN inhibitor."
A ligand-binding defective insulin receptor would reduce PI3K/AKT signaling, leading to increased FOXO activity and increased GeneX expression.
PTEN inhibition would increase PI3K/AKT signaling, which would reverse the effects of the defective insulin receptor by inhibiting FOXO activity and reducing GeneX expression.
Therefore, Statement C is correct, as PTEN inhibition compensates for reduced PI3K signaling, leading to a partial reversal of changes in GeneX expression caused by the defective insulin receptor.
Statement D: -"Phosphorylation of FOXO by PDK1 creates a phosphoserine binding site for 14-3-3 protein, reducing GeneX expression."
PDK1 is involved in activating AKT, which subsequently phosphorylates FOXO at specific residues.
When FOXO is phosphorylated, it binds 14-3-3 proteins, which sequester FOXO in the cytoplasm and prevent it from activating GeneX expression.
However, PDK1's role is to activate AKT and does not directly involve FOXO phosphorylation in the described mechanism. The AKT/FOXO pathway mainly governs GeneX expression.
Statement D is misleading or incorrect because it misrepresents the role of PDK1 and FOXO phosphorylation in this context.
